EZ Cap™ mCherry mRNA (5mCTP, ψUTP): High-Stability Cap 1 Red Fluorescent Reporter

Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic, Cap 1-structured messenger RNA encoding the monomeric red fluorescent protein mCherry. It integrates 5-methylcytidine (5mCTP) and pseudouridine (ψUTP) to minimize innate immune activation and boost mRNA stability (ApexBio product page). The mRNA is ~996 nucleotides in length, supplied at ~1 mg/mL in 1 mM sodium citrate, pH 6.4, and features a poly(A) tail for translation efficiency. Cap 1 capping is enzymatically conferred using Vaccinia Capping Enzyme, ensuring efficient translation and mimicking native mammalian mRNA (Roach 2024). This reagent is validated for robust, long-lasting reporter gene expression and is suitable for advanced cell tracking and molecular imaging workflows.

Biological Rationale

mCherry is a monomeric red fluorescent protein derived from Discosoma's DsRed, widely used as a molecular marker due to its photostability and brightness. The mCherry coding sequence is approximately 711 base pairs (FPbase). Fluorescent protein mRNAs are central to live-cell imaging, tracking cell components, and quantifying gene expression through real-time fluorescence (Roach 2024). Synthetic mRNAs, when engineered with 5mCTP and ψUTP, demonstrate reduced RNA-mediated innate immune activation and improved intracellular persistence, addressing key limitations of unmodified transcripts (Related article). Cap 1 capping further enhances translation efficiency by mimicking the 5' structure of mammalian mRNA, facilitating ribosome recruitment and protecting against exonuclease degradation. The poly(A) tail promotes translation initiation and mRNA stability, ensuring consistent protein output.

Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is synthesized via in vitro transcription, incorporating 5mCTP and ψUTP in place of standard CTP and UTP. This modification alters the mRNA's pattern recognition by innate immune sensors (e.g., TLR3, TLR7/8), reducing interferon-mediated responses and translation shutdown (Internal benchmark). The enzymatically added Cap 1 structure (m7GpppNm) is generated using Vaccinia Capping Enzyme, GTP, S-adenosylmethionine (SAM), and 2′-O-Methyltransferase. Cap 1 increases translational yield and stability in eukaryotic cells compared to Cap 0 or uncapped RNA. The ~996 nucleotide mRNA includes a 5' UTR, optimally codon-optimized mCherry CDS, and a poly(A) tail, ensuring maximal translation and persistence. The mRNA is formulated at ~1 mg/mL in 1 mM sodium citrate, pH 6.4, supporting stability during storage and handling. Storage at or below -40°C is recommended to preserve activity (ApexBio).

Evidence & Benchmarks

• Incorporation of 5mCTP and ψUTP in synthetic mRNAs suppresses RNA-mediated innate immune activation and increases mRNA stability in vitro and in vivo (Roach 2024, Table 2).
• Cap 1-structured mRNAs demonstrate higher translation efficiency in mammalian cells compared to Cap 0 or uncapped forms (Internal benchmark).
• mCherry fluorescence peaks at 610 nm (emission) with excitation at 587 nm, enabling high-contrast cellular imaging (FPbase).
• Poly(A) tails enhance translation initiation and extend mRNA half-life under physiological conditions (Applied Strategies article).
• Storage at or below -40°C maintains mRNA stability for at least 12 months with minimal degradation (ApexBio).
• Reporter mRNA tools like EZ Cap™ mCherry mRNA enable real-time tracking of cell localization and gene expression with high reproducibility (Cap 1 Reporter mRNA article).

Applications, Limits & Misconceptions

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is optimized for use as a reporter gene in mammalian cell transfection, live-cell imaging, and molecular tracking workflows. It supports applications in nanoparticle delivery, functional genomics, and high-content screening where immune-evasive, stable fluorescence is required (Related high-fidelity article – this article provides updated stability and workflow parameters that extend the discussion of high-fidelity cell imaging). It is not suitable for use in prokaryotic systems, as bacterial translation machinery does not recognize the eukaryotic mRNA cap or poly(A) tail. The product is validated for in vitro and in vivo eukaryotic research, with limitations in in vivo immunogenic animal models if formulated or delivered improperly. Fluorescent signal may be affected by photobleaching under continuous high-intensity illumination.

Common Pitfalls or Misconceptions

• EZ Cap™ mCherry mRNA cannot circumvent delivery barriers—efficient uptake depends on the chosen transfection or nanoparticle system.
• The reagent does not directly modify endogenous gene expression; it only provides transient fluorescent protein expression.
• It is not intended for clinical or diagnostic use in humans without further regulatory validation.
• The mRNA structure is optimized for eukaryotic systems; it will not translate in bacterial or cell-free systems lacking eukaryotic translation factors.
• Improper storage above -40°C can compromise RNA integrity and reduce expression efficiency.

Workflow Integration & Parameters

For optimal use, thaw EZ Cap™ mCherry mRNA (5mCTP, ψUTP) on ice and dilute in RNase-free buffer immediately prior to transfection. Typical working concentrations range from 10 ng/μL to 1 μg/μL, depending on cell type and application. Delivery methods include lipid nanoparticles, electroporation, and polymer-based reagents (Roach 2024). Polymeric mesoscale nanoparticles have demonstrated high mRNA loading efficiency and stability when combined with excipients like trehalose and calcium acetate. Quality controls should include RNA integrity analysis (e.g., Bioanalyzer), fluorescence microscopy, and flow cytometry to confirm expression kinetics and localization. For long-term storage, aliquot and freeze at -80°C if possible; avoid repeated freeze-thaw cycles (ApexBio).

This article extends prior internal content by detailing verified quantitative benchmarks, storage parameters, and clarifying cell system compatibility, addressing gaps in immune-evasive Cap 1 mRNA and high-stability reporter mRNA articles.

Conclusion & Outlook

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) combines Cap 1 capping, nucleotide modifications, and a poly(A) tail to deliver robust, long-lived red fluorescence in eukaryotic cells. Its immune-evasive design and proven storage stability make it a gold standard for molecular imaging, cell tracking, and advanced reporter gene studies. Future directions include further optimization for in vivo delivery and multiplexed imaging applications. For technical details, protocols, and updated data, visit the EZ Cap™ mCherry mRNA (5mCTP, ψUTP) product page.